These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 17884183)
21. Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid. Teleshova N; Pashenkov M; Huang YM; Söderström M; Kivisäkk P; Kostulas V; Haglund M; Link H J Neurol; 2002 Jun; 249(6):723-9. PubMed ID: 12111306 [TBL] [Abstract][Full Text] [Related]
22. Resequencing of the CCL5 and CCR5 genes and investigation of variants for association with diabetic nephropathy. Pettigrew KA; McKnight AJ; Patterson CC; Kilner J; Sadlier DM; Maxwell AP J Hum Genet; 2010 Apr; 55(4):248-51. PubMed ID: 20203694 [TBL] [Abstract][Full Text] [Related]
24. Association of the MMP-3 5A/6A gene polymorphism with multiple sclerosis in patients from Serbia. Djurić T; Zivković M; Stanković A; Dincić E; Raicević R; Alavantić D J Neurol Sci; 2008 Apr; 267(1-2):62-5. PubMed ID: 17942123 [TBL] [Abstract][Full Text] [Related]
25. CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan. Konishi I; Horiike N; Hiasa Y; Michitaka K; Onji M Intervirology; 2004; 47(2):114-20. PubMed ID: 15192276 [TBL] [Abstract][Full Text] [Related]
26. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE. Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785 [TBL] [Abstract][Full Text] [Related]
27. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. Sørensen TL; Tani M; Jensen J; Pierce V; Lucchinetti C; Folcik VA; Qin S; Rottman J; Sellebjerg F; Strieter RM; Frederiksen JL; Ransohoff RM J Clin Invest; 1999 Mar; 103(6):807-15. PubMed ID: 10079101 [TBL] [Abstract][Full Text] [Related]
28. Multiple sclerosis: an immune or neurodegenerative disorder? Trapp BD; Nave KA Annu Rev Neurosci; 2008; 31():247-69. PubMed ID: 18558855 [TBL] [Abstract][Full Text] [Related]
29. Chemokine receptor expression on T cells is related to new lesion development in multiple sclerosis. Eikelenboom MJ; Killestein J; Izeboud T; Kalkers NF; van Lier RA; Barkhof F; Uitdehaag BM; Polman CH J Neuroimmunol; 2002 Dec; 133(1-2):225-32. PubMed ID: 12446027 [TBL] [Abstract][Full Text] [Related]
30. MRI as a marker for disease heterogeneity in multiple sclerosis. Bielekova B; Kadom N; Fisher E; Jeffries N; Ohayon J; Richert N; Howard T; Bash CN; Frank JA; Stone L; Martin R; Cutter G; McFarland HF Neurology; 2005 Oct; 65(7):1071-6. PubMed ID: 16217061 [TBL] [Abstract][Full Text] [Related]
31. Association of polymorphisms in CTLA-4, IL-1ra and IL-1beta genes with multiple sclerosis in Serbian population. Dincić E; Zivković M; Stanković A; Obradović D; Alavantić D; Kostić V; Raicević R J Neuroimmunol; 2006 Aug; 177(1-2):146-50. PubMed ID: 16769128 [TBL] [Abstract][Full Text] [Related]
32. CCR5Δ32 - A piece of protection in the inflammatory puzzle of multiple sclerosis susceptibility. Troncoso LL; Pontillo A; Oliveira EML; Finkelszteijn A; Schneider S; Chies JAB Hum Immunol; 2018 Aug; 79(8):621-626. PubMed ID: 29729320 [TBL] [Abstract][Full Text] [Related]
33. Delta32 polymorphism of the chemokine receptor CCR5 in a patient with multifocal motor neuropathy. Trebst C; Heiken H; Schmidt RE; Windhagen A; Stangel M Muscle Nerve; 2007 Apr; 35(4):541-2. PubMed ID: 17266130 [No Abstract] [Full Text] [Related]
34. Interleukin-24, RANTES and CCR5 gene polymorphisms are not associated with chronic adult periodontitis. Savarrio L; Donati M; Carr C; Kinane DF; Berglundh T J Periodontal Res; 2007 Apr; 42(2):152-8. PubMed ID: 17305874 [TBL] [Abstract][Full Text] [Related]
35. Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib. Suenaga M; Schirripa M; Cao S; Zhang W; Yang D; Ning Y; Cremolini C; Antoniotti C; Borelli B; Mashima T; Okazaki S; Berger MD; Miyamoto Y; Gopez R; Barzi A; Lonardi S; Yamaguchi T; Falcone A; Loupakis F; Lenz HJ Clin Colorectal Cancer; 2018 Jun; 17(2):e395-e414. PubMed ID: 29606345 [TBL] [Abstract][Full Text] [Related]
36. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857 [TBL] [Abstract][Full Text] [Related]
37. P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis. Scalabrini D; Galimberti D; Fenoglio C; Comi C; De Riz M; Venturelli E; Castelli L; Piccio L; Ronzoni M; Lovati C; Mariani C; Monaco F; Bresolin N; Scarpini E Neurosci Lett; 2005 Nov; 388(3):149-52. PubMed ID: 16039046 [TBL] [Abstract][Full Text] [Related]
38. The pathology of MS: new insights and potential clinical applications. Pittock SJ; Lucchinetti CF Neurologist; 2007 Mar; 13(2):45-56. PubMed ID: 17351524 [TBL] [Abstract][Full Text] [Related]
39. A mutated CCR5 gene may have favorable prognostic implications in MS. Kantor R; Bakhanashvili M; Achiron A Neurology; 2003 Jul; 61(2):238-40. PubMed ID: 12874407 [TBL] [Abstract][Full Text] [Related]